Accounting for Emergence and Novelty in Boston and Bay Area Biotechnology
暂无分享,去创建一个
[1] A. Chandler,et al. Regional Advantage: Culture and Competition in Silicon Valley and Route 128 , 1994 .
[2] L. Galambos,et al. The pharmaceutical industry in the twentieth century: A reappraisal of the sources of innovation , 1996 .
[3] J. Ruiz Moreno. [Organizational learning]. , 2001, Revista de enfermeria.
[4] Stanley Wasserman,et al. Social Network Analysis: Methods and Applications , 1994, Structural analysis in the social sciences.
[5] B. Spilker,et al. Science and Innovation: The US Pharmaceutical Industry During the 1980s , 1996 .
[6] Richard R. Nelson,et al. Assessing Private Enterprise: An Exegesis of Tangled Doctrine , 1981 .
[7] Kenneth W. Koput,et al. The Spatial Clustering of Science and Capital: Accounting for Biotech Firm-Venture Capital Relationships , 2002 .
[8] Paula E. Stephan,et al. Company-Scientist Locational Links: The Case of Biotechnology , 1996 .
[9] Walter W. Powell,et al. A Comparison of U.S. and European University-Industry Relations in the Life Sciences , 2001 .
[10] O. Sorenson,et al. Technology as a complex adaptive system: evidence from patent data , 2001 .
[11] G. Dosi. Technological Paradigms and Technological Trajectories: A Suggested Interpretation of the Determinants and Directions of Technical Change , 1982 .
[12] W. Powell,et al. Network Dynamics and Field Evolution: The Growth of Interorganizational Collaboration in the Life Sciences1 , 2005, American Journal of Sociology.
[13] D. Teece. Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .
[14] Cynthia Robbins-Roth,et al. From alchemy to IPO : the business of biotechnology , 2000 .
[15] Toby E. Stuart,et al. The geography of opportunity: spatial heterogeneity in founding rates and the performance of biotechnology firms , 2003 .
[16] M. Trajtenberg. A Penny for Your Quotes : Patent Citations and the Value of Innovations , 1990 .
[17] F. Malerba,et al. The Geography of Innovation and Economic Clustering: Some Introductory Notes , 2001 .
[18] Manuel Trajtenberg,et al. Patents, Citations, and Innovations: A Window on the Knowledge Economy , 2002 .
[19] J. Hagedoorn,et al. Small entrepreneurial firms and large companies in inter-firm R&D networks - the international biotechnology industry , 1993 .
[20] M. Feldman. The Entrepreneurial Event Revisited: Firm Formation in a Regional Context , 2001 .
[21] M. Feldman,et al. Innovation in Cities: Science-Based Diversity, Specialization and Localized Competition , 1999 .
[22] Massimo Riccaboni,et al. Technological change and network dynamics: Lessons from the pharmaceutical industry , 2001 .
[23] W. Powell,et al. Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .
[24] Chaomei Chen,et al. Patents, citations & innovations: A window on the knowledge economy , 2003, J. Assoc. Inf. Sci. Technol..
[25] Edward M. Reingold,et al. Graph drawing by force‐directed placement , 1991, Softw. Pract. Exp..
[26] B. Kogut,et al. Localization of Knowledge and the Mobility of Engineers in Regional Networks , 1999 .
[27] Harold E. Varmus,et al. Genes and the Biology of Cancer , 1992, Nature Medicine.
[28] L. Zucker,et al. Present at the biotechnological revolution: transformation of technological identity for a large incumbent pharmaceutical firm , 1997 .
[29] Martha Prevezer,et al. The Dynamics of Industrial Clustering in Biotechnology , 1997 .
[30] Michael Konrad,et al. Biotechnology: The university-industrial complex , 1987, Journal of Genetics.
[31] Satoru Kawai,et al. An Algorithm for Drawing General Undirected Graphs , 1989, Inf. Process. Lett..
[32] T. Bresnahan,et al. ‘Old Economy’ Inputs for ‘New Economy’ Outcomes: Cluster Formation in the New Silicon Valleys , 2001 .
[33] Walter W. Powell,et al. Inter-Organizational Collaboration in the Biotechnology Industry , 1996 .
[34] L. Zucker,et al. Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] Franco Malerba,et al. Clusters, networks, and innovation , 2005 .
[36] Richard R. Nelson,et al. Institutions Supporting Technical Advance in Industry , 1986 .
[37] I. Cockburn,et al. Scale, scope, and spillovers: the determinants of research productivity in drug discovery. , 1996, The Rand journal of economics.
[38] Maureen McKelvey. Evolutionary Innovations: The Business of Biotechnology , 1996 .
[39] D. Teece. Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .
[40] Luigi Orsenigo,et al. The emergence of biotechnology , 1989 .